Literature DB >> 31737929

Heterogeneity of Triple-Negative Breast Cancer: Differences in Clinicopathologic and Ultrasound Features Between Premenopausal and Postmenopausal Patients.

Kai Zhu1, Dongmo Wang2, Ziyao Li2, Guoqing Du2, Qiang Guo3, Tong Wu2, Juan Li2.   

Abstract

OBJECTIVES: The aim of this study was to determine whether any salient differences exist in triple-negative breast cancer (TNBC) between premenopausal and postmenopausal patients by comprehensively comparing the ultrasound (US) and clinicopathologic features of these patients.
METHODS: A detailed evaluation of the US and clinicopathologic features of 60 tumors from 60 patients with a diagnosis of TNBC (36 premenopausal and 24 postmenopausal women) was conducted in this retrospective study.
RESULTS: Triple-negative breast cancer in premenopausal patients was more likely to show a round or oval shape and microlobulated margins, more commonly exerted effects on surrounding tissue, and showed grade 3 blood flow according to the method of Adler et al (Ultrasound Med Biol 1990; 16:553-559) compared with tumors in postmenopausal women. Triple-negative breast cancer in postmenopausal patients showed some similar US features as those observed in estrogen receptor-positive tumors, including irregular shapes, angular or spiculated margins, and nonparallel growth to the skin (P < .05 for all).
CONCLUSIONS: Although US cannot be used to unequivocally identify TNBC, it can distinguish some salient US features regarding TNBC between premenopausal and postmenopausal women. Such information can then provide some valuable predictive information on the diagnosis of TNBC for clinicians.
© 2019 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  clinical pathology; diagnosis; menopause; triple-negative breast cancer; ultrasound

Mesh:

Year:  2019        PMID: 31737929     DOI: 10.1002/jum.15174

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  2 in total

1.  Calcification, Posterior Acoustic, and Blood Flow: Ultrasonic Characteristics of Triple-Negative Breast Cancer.

Authors:  Kangjian Wang; Zongkai Zou; Haolin Shen; Guimei Huang; Shuping Yang
Journal:  J Healthc Eng       Date:  2022-09-26       Impact factor: 3.822

2.  Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy.

Authors:  Ranjita Misra; Bamadeb Patra; Sudha Varadharaj; Rama Shanker Verma
Journal:  Bioimpacts       Date:  2020-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.